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M I C R O B I O L O G Y
Ca2+ signals critical for egress and gametogenesis 
in malaria parasites depend on a multipass membrane 
protein that interacts with PKG
Aurélia C. Balestra1*, Konstantinos Koussis2*†, Natacha Klages1, Steven A. Howell3,  
Helen R. Flynn3, Marcus Bantscheff4, Carla Pasquarello5, Abigail J. Perrin2, Lorenzo Brusini1, 
Patrizia Arboit5, Olalla Sanz6, Laura Peces-Barba Castaño2, Chrislaine Withers-Martinez2, 
Alexandre Hainard5, Sonja Ghidelli-Disse4, Ambrosius P. Snijders3, David A. Baker7,  
Michael J. Blackman2,7†, Mathieu Brochet1†
Calcium signaling regulated by the cGMP-dependent protein kinase (PKG) controls key life cycle transitions in the 
malaria parasite. However, how calcium is mobilized from intracellular stores in the absence of canonical calcium 
channels in Plasmodium is unknown. Here, we identify a multipass membrane protein, ICM1, with homology to 
transporters and calcium channels that is tightly associated with PKG in both asexual blood stages and transmission 
stages. Phosphoproteomic analyses reveal multiple ICM1 phosphorylation events dependent on PKG activity. 
Stage-specific depletion of Plasmodium berghei ICM1 prevents gametogenesis due to a block in intracellular calcium 
mobilization, while conditional loss of Plasmodium falciparum ICM1 is detrimental for the parasite resulting in 
severely reduced calcium mobilization, defective egress, and lack of invasion. Our findings suggest that ICM1 is a 
key missing link in transducing PKG-dependent signals and provide previously unknown insights into atypical 
calcium homeostasis in malaria parasites essential for pathology and disease transmission.
INTRODUCTION
Malaria is an important cause of global morbidity and mortality, 
accounting for around 405,000 deaths in 2018 (1). The disease is caused 
by parasites of the genus Plasmodium, which have a remarkable life 
cycle with multiple cellular differentiation events in both humans 
and mosquitoes. To sense and respond to changes in these very dif-
ferent environments, malaria parasites use an intracellular commu-
nication system that relies on intracellular messengers and protein 
kinases. Two key signaling molecules in these pathways are 3′,5′- 
guanosine monophosphate (cGMP) and calcium, both of which 
regulate pivotal processes in most eukaryotes (2, 3).
The sole sensor of cGMP in malaria parasites is the cGMP- 
dependent protein kinase (PKG), which plays vital roles in most stages 
of the parasite life cycle, including the asexual blood stages that cause 
all the manifestations of clinical malaria. These roles include con-
trol of cellular events required to trigger release of merozoites from 
red blood cells (RBCs) (4, 5) and hepatocytes (6), induction of game-
togenesis and parasite transmission upon ingestion of gametocytes 
by a blood-feeding mosquito (7), and sustaining cellular motility 
necessary for parasite dissemination (8, 9). A major function of PKG 
in all these processes is the tightly regulated mobilization of calcium 
from intracellular stores within seconds of activation (8, 10).
In mammalian cells, one of the two PKG isoforms, cGKI (or 
PKG1), is a well-established regulator of calcium homeostasis. cGKI 
activation lowers intracellular free calcium upon stimulation by ni-
tric oxide, favoring smooth muscle relaxation or decreasing platelet 
activation (11). cGKI-dependent phosphorylation is known to reg-
ulate levels of cytosolic calcium via distinct mechanisms, including 
either decreased calcium influx by l-type calcium channels (12) or 
sequestration of calcium within intracellular stores. Increased calci-
um sequestration can be mediated by the phosphorylation of (i) the 
inositol 1,4,5-trisphosphate (IP3) receptor–associated cGMP-kinase 
substrate (IRAG), which reduces calcium release from intracellular 
stores by IP3 receptors (13); or (ii) phospholipase-C 3, decreasing 
IP3 generation and subsequent calcium mobilization (14); or (iii) 
phospholamban, which enhances calcium sequestration by the sar-
coplasmic reticulum calcium/adenosine triphosphatase (ATPase) 
pump (15). Plasmodium parasites are highly divergent from their 
mammalian hosts (16), and no genes encoding clear homologs of 
IRAG, IP3 receptors, phospholamban, or l-type calcium channels 
have been identified in their genomes (3).
In the absence from Plasmodium of such key signaling molecules, 
it remains unknown how calcium is mobilized from intracellular 
stores. We reasoned that the identification of PKG-interacting pro-
teins in Plasmodium would provide valuable new insights into cal-
cium homeostasis. Here, we identify a multipass membrane protein, 
termed important for calcium mobilization-1 (ICM1; Pf3D7_ 
1231400) that interacts with and is phosphorylated by PKG in two 
different Plasmodium developmental stages and species. Through 
stage-specific knockdown and reverse genetic approaches, we show 
that ICM1 is essential for calcium mobilization in both the clinical-
ly relevant asexual blood stages and in gametocytes that mediate 
transmission to mosquitoes. Our findings highlight this putative 
transporter or channel as a crucial link between PKG function and 
calcium signaling.
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RESULTS
Plasmodium PKG interacts with ICM1, a multipass membrane 
protein, in both asexual and sexual stages
To identify potential PKG-interacting partners in Plasmodium 
falciparum, we used a previously established transgenic parasite line 
expressing PKG fused at its C terminus to a triple hemagglutinin (HA) 
tag (PfPKG-HA) (17). PfPKG-HA was immunoprecipitated from 
extracts of mature schizonts using anti-HA–conjugated magnetic 
beads and the eluates analyzed by quantitative tandem mass spectrom-
etry (MS/MS). The most enriched protein coimmunoprecipitated with 
PfPKG-HA was identified with high confidence as Pf3D7_1231400, 
annotated as a putative amino acid transporter (www.plasmodb.org), 
but henceforth referred to as ICM1 (Fig. 1A and data S1). To corrob-
orate these findings, we generated a second transgenic P. falciparum 
line expressing a green fluorescent protein (GFP)–tagged PKG 
(PKG-GFP) (fig. S1, A to E). Mass spectrometric analysis of pull-
downs from extracts of these parasites using anti-GFP nanobodies 
similarly identified PfICM1 as a top hit (fig. S1F and data S1).
To independently validate the putative interaction between ICM1 
and PKG, we took an orthogonal chemical proteomics approach. A 
potent PKG inhibitor (18) (ML10) was used on a Kinobead matrix 
(19) to identify the repertoire of P. falciparum proteins targeted by 
this compound. Proteomic profiling showed that ML10 prevented 
the binding of just four parasite proteins to kinase inhibitors; these 
were PfPKG, two calcium-dependent protein kinases (CDPK1 and 
CDPK4), and PfICM1. The selectivity of ML10 for Plasmodium 
PKG exploits the presence of a small threonine gatekeeper residue 
in the enzyme adenosine triphosphate binding pocket (18). As both 
CDPK1 and CDPK4 also have small serine gatekeeper residues (20), 
it is likely that ML10 binds these two kinases directly. However, iden-
tification of a nonkinase hit in the Kinobead experiments likely 
reflects either off-target effects of the compound or capture of 
kinase-associated proteins. These results, combined with the pull-
down data, fully support a direct interaction between PKG and ICM1 
(Fig. 1B and data S1).
To interrogate whether the interaction between PKG and ICM1 
is conserved across Plasmodium species and developmental stages, 
we exploited a previously described transgenic Plasmodium berghei 
line expressing HA3-tagged PKG (PbPKG-HA3) (8) to immuno-
precipitate PbPKG-HA3 from extracts of schizonts and gametocytes. 
Quantitative MS showed that in both stages, PbICM1 (PBANKA_ 
1446100) was the most enriched protein coimmunoprecipitated 
with PbPKG-HA3 (Fig. 1, C and D, and data S1). To further validate 
these results in a reciprocal manner, we generated a PbICM1-HA3 
line (fig. S1G). No signal was observed for PbICM1-HA3 in Western 
blot analysis of schizont or gametocyte extracts from this line, pos-
sibly due to low abundance of PbICM1. Consistent with this obser-
vation, no specific immunofluorescence signal could be observed in 
both schizonts and gametocytes. Nevertheless, immunoprecipitation 
(IP) of PbICM1-HA3 from extracts of both schizonts and gameto-
cytes recovered multiple peptides, identified by MS to encompass 
up to 28% coverage of PbICM1. As expected, based on the PbPKG 
IPs, PbPKG was the most enriched protein coimmunoprecipitated 
with PbICM1-HA3 in both stages (Fig. 1, C and D, and data S1). 
Notably, no peptides from PbCDPK1 or PbCDPK4 were recovered 
from either immunoprecipitate, confirming that these kinases do not 
interact with PbPKG or PbICM1 as previously suggested (10).
To further characterize the specificity of PbPKG and PbICM1 
co-IPs in gametocytes, we compared the relative abundance of proteins 
recovered in both immunoprecipitates with those of seven other 
proteins involved in gametogenesis (21). Nine-dimensional princi-
pal components analysis (PCA) of all detected proteins confirmed 
the clustering of PbPKG and PbICM1, consistent with the forma-
tion of a complex (Fig. 1D). Together, these results demonstrate a 
conserved interaction between ICM1 and PKG in at least two devel-
opmental stages of two different Plasmodium species.
Modeling of ICM1 shows resemblance to transporters 
and channels
ICM1 is a multipass membrane protein annotated as a putative amino 
acid transporter. A single ICM1 ortholog is present in all sequenced 
Plasmodium genomes, but no orthologs are evident in nonapicom-
plexan genomes. The N-terminal segment, which encompasses two 
conserved clusters of five and four transmembrane domains (TMDs), 
Fig. 1. PKG interacts with ICM1 in P. falciparum and P. berghei schizonts and in P. berghei gametocytes. (A) Volcano plot depicting relative abundance of proteins 
identified by quantitative MS in pull-downs from P. falciparum PKG-HA compared to WT (control) parasites (n = 3). Significance (Student’s t test) is expressed as log10 of 
the P value (y axis). X axis, enrichment of interaction partners in the P. falciparum PKG-HA pull-down compared to controls. (B) Competitive chemoproteomic studies using 
Kinobeads on extracts of P. falciparum schizonts. (C) Mass spectrometric quantitation of proteins immunoprecipitated from extracts of P. berghei PKG-HA3 (n = 1) and 
ICM1-HA3 (n = 1) schizonts. ND, not detected (D) Mass spectrometric spectral count values for proteins copurifying with PbPKG-HA3 (n = 2) and PbICM1-HA3 (n = 2) ga-
metocytes following IP and displayed in the first and second principal components compared with previously published IPs of CRK5, CDKrs, SOC2, CDPK4, SOC1, SOC3, 
and MCM5.
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respectively, shows high levels of identity between the P. falciparum 
and P. berghei orthologs, and these nine TMDs are also conserved 
in Plasmodium yoelii, Plasmodium vivax, Plasmodium chabaudi, 
and Plasmodium knowlesi (data S2). This region is separated from a 
predicted C-terminal TMD (TMD10) by ~1100 amino acid residues 
that are less conserved between all species. Homology modeling 
using Phyre2 (22) suggests weak similarity of the ICM1 N terminus 
to cation transporters, amino acid transporters, or IP3 receptors 
(fig. S2A). To investigate this further, the Iterative Threading 
ASSEmbly Refinement (I-TASSER) approach was used to model 
the N-terminal 1500 residues of P. falciparum ICM1. Following 
structure assembly simulation, the Protein Data Bank (PDB) was 
screened for proteins with the closest structural similarity to the 
model. The top PDB hit was an IP3 receptor (rat cerebellum InsP3R1, 
PDB: 6MU1) with a template modelling score of 0.967, a root mean 
square deviation of 2.06 Å, and a coverage of 98.7%, although 
amino acid identity between the two proteins was very low (8.4%) 
(fig. S2B). However, our analyses did not identify any domains sim-
ilar to other calcium channels such as IP3-binding domains or Ca2+ 
binding sites. Collectively, these findings suggest that ICM1 may 
represent a structurally divergent polytopic membrane protein with 
architectural similarities to mammalian channels, transporters, and 
IP3 receptors.
ICM1 is phosphorylated in a PKG-dependent manner
The physical interaction between PKG and ICM1 raised the possi-
bility of PKG regulating the function of ICM1 through phosphory-
lation. Several global phosphoproteome studies in Plasmodium 
have identified multiple phosphorylation sites between TMD9 and 
TMD10 in both P. falciparum ICM1 (23–25) and PbICM1 (8, 26). 
In a previous study, pharmacological inhibition of PKG activity in 
mature schizonts did not detect any differential ICM1 phosphorylation 
under the tested conditions (25). However, a phosphoproteome 
analysis of P. berghei guanylyl cyclase beta (GC) mutant ookinetes, in 
which PKG activity is down-regulated (27), showed that PbICM1-S1288 
was significantly less phosphorylated in this transgenic line (8). To 
shed more light on PKG-dependent phosphorylation of ICM1, we 
profiled the PKG-dependent phosphoproteomes in both gameto-
cytes and schizonts. For the former, we examined phosphorylation 
events just 15 s after activation of gametocytes in the presence or 
absence of a selective PKG inhibitor (compound A) (10, 28), as 
PbPKG activity during gametogenesis is only required during the 
first 15  s following stimulation by xanthurenic acid (XA) (8,  10). 
Compound A was used at 1 M, a concentration that did not impair 
exflagellation of a line expressing a resistant PKGT619Q-HA allele 
indicating the selectivity of this small molecule under these experi-
mental conditions (10). In the case of P. falciparum schizonts, we 
generated a conditional knockout (cKO) of PKG to investigate the 
phosphoproteome changes in PKG-null mutants. Treatment of this 
line, termed pfpkg:cKO, with rapamycin (RAP) results in disruption 
of the pfpkg gene, expression of mCherry, and complete arrest of 
parasite replication due to the requirement of PKG for merozoite 
egress (fig. S3 and movie S1) (5).
Given the low abundance of PbICM1 in gametocytes, we used 
SDS–polyacrylamide gel electrophoresis (PAGE) fractionation to 
enrich for proteins of molecular mass between 180 and 220 kDa. 
Analysis of these proteins identified 957 phosphopeptides mapping 
onto 610 proteins (data S3). Upon pharmacological inhibition of 
PbPKG, 410 phosphopeptides were less phosphorylated, a large response 
amplitude that probably reflects the early requirement for PbPKG 
during gametogenesis (Fig. 2A). Conditional disruption of PfPKG 
had a similarly profound effect on the P. falciparum global schizont 
phosphoproteome, with more than 1000 phosphopeptides being sig-
nificantly hypophosphorylated (Fig. 2B and data S4). Gene Ontology 
(GO) term enrichment analysis of hypophosphorylated proteins in 
P. berghei gametocytes suggested deregulation of both synthesis and 
mitosis cell cycle phases, which are initiated by calcium mobilization 
(Fig. 2C and data S3) (26, 29, 30). A similar analysis of the hypo-
phosphorylated proteins in P. falciparum schizonts suggested po-
tential defects in RNA processing and splicing (Fig. 2D and data S4).
The previously identified cGMP-dependent phosphorylation of 
enzymes involved in the metabolism of inositol phospholipids in 
P. berghei ookinetes (8, 10) was confirmed here for both schizonts 
and gametocytes. We then focused our attention on ICM1 phos-
phorylation. Twelve PfICM1 phosphorylation sites were mapped in 
P. falciparum schizonts (Fig. 2B). Ten sites were hypophosphorylated 
in the absence of PfPKG, suggesting a general defect in phosphory-
lation of PfICM1 although only two sites (S1289 and S1875) exhib-
ited a fold change of more than 1.8. In gametocytes, intensities of 
the eight nonphosphorylated peptides mapped onto PbICM1 were 
not affected by compound A, indicating that PbICM1 abundance is 
not dependent on PbPKG activity. We identified two PbICM1 phos-
phosites, of which S1145 was significantly down-regulated upon 
PbPKG inhibition. Phosphorylation of PbICM1-S1145 was previ-
ously shown to be up-regulated within seconds of gametocyte acti-
vation by XA (26) and so possibly represents an important event in 
PbICM1 regulation. We additionally interrogated the phosphoryla-
tion status of immunoprecipitated PbICM1-HA3  in gametocytes 
15 s after activation, in the presence or absence of 1 M compound 
A (Fig. 2E). Treatment with compound A had no effect on the inter-
action between PbPKG and PbICM1-HA3 or on the obtained coverage 
of PbICM1-HA3. However, S1203 was the only residue detected as 
phosphorylated following gametocyte activation by XA, and no 
phosphorylation of PbICM1-HA3 was detected upon inhibition of 
PbPKG. This suggests that ICM1-S1203 is also phosphorylated ear-
ly during gametogenesis in a PKG-dependent manner.
Collectively, our results indicate that the phosphorylation of at 
least five ICM1 residues depends on PKG activation. Four of the 
detected PKG-dependent phosphorylation sites are clustered in a 
region encompassing residues Pf1162 (Pb1145) to Pf1357 (Pb1288), 
suggesting that this represents an important region for regulation of 
ICM1 function (Fig. 2F).
Stage-specific knockdown of PbICM1 reveals a  
crucial role in early calcium mobilization required  
to initiate gametogenesis
To study the function and essentiality of PbICM1 during gameto-
genesis, we first attempted to disrupt the pbicm1 gene. The gene was 
previously suggested to be resistant to disruption in a global gene 
KO study (31), although a transient nonclonal population of para-
sites lacking icm1 had been observed in the days following transfec-
tion in an independent study (32). We were here however unable to 
obtain a clonal icm1-KO population despite four independent at-
tempts using highly efficient PlasmoGEM vectors (33, 34). We then 
tagged endogenous ICM1 with an auxin-inducible degron (AID) 
coupled to an HA epitope tag (fig. S4A) to allow degradation of the 
fusion protein in the presence of auxin in a strain expressing the 
Tir1 protein (35). Addition of auxin to PbICM1-AID/HA gametocytes 
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did not lead to any defect in male gametogenesis. However, we could 
detect no Western blot signal for PbICM1-AID/HA; thus, we were 
unable to confirm successful degradation of the protein upon auxin 
treatment (fig. S4B). We thus opted for a stage-specific knockdown 
of PbICM1 by placing the endogenous pbicm1 gene under the con-
trol of the pbama1 promoter, which is active in schizonts but virtu-
ally silent in gametocytes (36). A Pama1ICM1 clone was readily 
obtained and reverse transcription quantitative polymerase chain 
reaction (PCR) analysis confirmed a two-fold reduction in pbicm1 
expression in purified Pama1ICM1 gametocytes (Fig. 3A).
To determine the requirement for PbICM1 during gametogene-
sis, we then compared the effect of pbicm1 down-regulation with 
PKG inhibition. Although Pama1ICM1 gametocytes were micro-
scopically indistinguishable from their wild-type (WT) counterparts, 
they did not form active exflagellation centers upon treatment with 
XA, phenocopying PKG-specific inhibition by 1 M compound A 
(Fig. 3B). A similar result was observed when pbicm1 was placed 
instead under the control of the clag9 promoter, which similarly 
down-regulates pbicm1 in gametocytes (fig. S4, C to E). In addition, 
PbICM1 down-regulation or PbPKG inhibition both led to significant 
Fig. 2. ICM1 is phosphorylated in a PKG-dependent manner. (A) Volcano plot showing the extent of differentially phosphorylated peptides in P. berghei gametocytes 
15 s after XA stimulation in presence or absence of compound A (CA) (n = 3). (B) Volcano plots showing differentially phosphorylated peptides in DMSO- and RAP-treated 
pfpkg:cKO schizonts (n = 5). Blue dots correspond to identified PfICM1 phosphosites and black dots to PfPKG phosphosites. (C and D) GO term enrichment analysis for 
down-regulated phosphopeptides in 15-s activated gametocytes upon inhibition of PbPKG by compound A and of PfPKG-null schizonts. For the latter, a cutoff of Welch 
difference of <−1 and >1 with P <0.05 and a localization probability of >0.7 represent a significantly regulated peptide. Representative terms are shown (for a full list of 
GO term enrichment analysis in PfPKG-null schizonts, see data S4). (E) Relative abundance of proteins coprecipitated with PbICM1-HA3 in 15-s activated gametocytes in 
the presence or absence of compound A. Inset: Representative spectra indicating that phosphorylation of PbICM1-S1203 is only detected in absence of compound A. 
(F) Schematic of PbICM1 and PfICM1 indicating predicted TMDs and phosphosites detected in this and previous studies.
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Fig. 3. Stage-specific knockdown of PbICM1 partially phenocopies PKG inhibition. (A) Relative levels of pbicm1 mRNA in WT and Pama1ICM1gametocytes. FC, fold 
change. (B) Knockdown of PbICM1 impairs exflagellation. (C) Pama1ICM1 male gametocytes show a strong reduction in fully assembled axonemes. Insets: Representative 
images. Scale bars, 2 m. (D) Proportion of male gametocytes undergoing DNA replication determined at 1 min postactivation (p.a.) and expressed as a percentage of 
polyploid (>1n) cells. Insets: Gating used for the analysis. (E) Egress from RBCs was quantified by flow cytometry based on the presence of the RBC membrane marker 
Ter-119 in gametocytes, 15 min p.a. Insets: IFA of WT and Pama1ICM1 gametocytes activated 15 min p.a. Scale bars, 2 m. (F) Fluorescence response kinetics of gametocytes 
loaded with Fluo-4 AM upon stimulation with 100 M XA. AUC, area under each curve. (G) Relative calcium response to 100 M XA of WT and Pama1ICM1 gametocytes 
upon treatment with compound 2. (H) Fluorescence response of gametocytes loaded with Fluo-4 AM upon stimulation with A23187. (I) Fluorescence response of 
gametocytes loaded with Fluo-4 AM upon stimulation with BIPPO. (J) cGMP levels in WT and Pama1ICM1 gametocytes upon stimulation with BIPPO. Error bars, ±SD; numbers 
of independent replicates are indicated for each experiment; two-tailed unpaired t test.
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decreases in axoneme formation, egress from the host RBC, and DNA 
replication, indicating an early requirement for PbICM1  in male 
gametogenesis (Fig. 3, C to E).
We previously showed that PKG is critical for mobilization of 
calcium from intracellular stores within seconds of gametocyte stimu-
lation by XA (8). Consistent with a functional link between PbPKG 
and PbICM1, a strongly attenuated calcium mobilization was con-
sistently observed in Pama1ICM1 and Pclag9ICM1 gametocytes (Fig. 3F 
and fig. S4F). The residual signal observed in Pama1ICM1 gameto-
cytes could possibly be due to incomplete silencing of icm1 or due 
to PbICM1-independent pathways downstream of PbPKG also in-
volved in calcium mobilization. The residual calcium mobilization 
observed in Pama1ICM1 gametocytes was 10 times more sensitive to 
PKG inhibition by compound 2 compared with WT parasites, fur-
ther strengthening the evidence for a functional interplay between 
PbPKG and PbICM1 (Fig. 3G). Pama1ICM1 and Pclag9ICM1 gameto-
cytes responded normally to the calcium ionophore A23187, indi-
cating similar levels of mobilizable intracellular calcium in Pama1ICM1 
and WT gametocytes (Fig. 3H and fig. S4G).
To define the functional requirement for PbICM1 in the first sec-
onds of gametogenesis, we took advantage of a phosphodiesterase 
(PDE) inhibitor, BIPPO, which elevates levels of cGMP in Plasmodium 
by preventing its degradation and leading to PKG activation (37). 
As expected, elevation of cGMP by BIPPO led to calcium release in 
WT gametocytes. In stark contrast, the calcium response to PDE 
inhibition was strongly reduced in the Pama1ICM1 line (Fig. 3I and 
fig. S4H). However, chemical inhibition of PDEs and XA stimula-
tion induced comparable cGMP levels in both WT and Pama1ICM1 
gametocytes, indicating that PbICM1 is not required to control 
cGMP homeostasis upstream of PKG (Fig. 3J). Together, these re-
sults indicate that PbICM1 is required for PKG-dependent mobili-
zation of intracellular calcium.
Loss of PfICM1 in asexual blood stages inhibits calcium 
mobilization leading to inefficient egress and invasion
To study the function of PfICM1 and its link to PKG function in 
P. falciparum asexual blood stages, we investigated the phenotypic 
consequences of PfICM1 disruption. Because pficm1 was predicted 
to be essential (38), we decided to disrupt the gene conditionally using 
the RAP-inducible DiCre system (39). Generation of the pficm1:cKO 
line was achieved in two steps using a marker-free Cas9-mediated 
strategy. In the first of these, we modified the 3′ end of the gene by 
fusing it to a C-terminal HA3 epitope tag followed by a loxN site, a 
T2A peptide and an out-of-frame GFP sequence (fig. S5, A and B). 
The pficm1:HA parasites displayed normal replication rates, indi-
cating that the modification had no impact on parasite fitness (fig. 
S5C). In a second gene manipulation step, we replaced intron 1 of 
pficm1 in the pficm1:HA line with a 2loxPint element (5), creating 
line pficm1:cKO (fig. S5D). DiCre-mediated recombination between 
the two loxN sites (one within the 2loxPint and one downstream of 
the HA tag) was predicted to severely truncate the pficm1 gene while 
simultaneously positioning the downstream GFP in frame, enabling 
its expression as a reporter of successful excision (fig. S5, E and F). 
Immunofluorescence (IFA) analysis of dimethyl sulfoxide (DMSO)– and 
RAP-treated schizonts of line pficm1:cKO alongside a WT control did 
show evidence of protein regulation but the very low levels of pro-
tein expression prevented us from localizing the protein (fig. S5G).
Monitoring of DMSO- and RAP-treated pficm1:cKO parasites 
under standard static culture conditions showed complete arrest of 
growth in the RAP-treated cultures (Fig. 4A). RAP-treated parasites 
formed morphologically normal mature schizonts at the end of the 
erythrocytic cycle of treatment (cycle 0), indicating no effects on intra-
cellular development. However, very few schizonts from the RAP- 
treated cultures underwent egress, resulting in a significant reduction 
in newly invaded rings (Fig. 4B). To seek further insights, we mon-
itored the behavior of DMSO- and RAP-treated pficm1:cKO schizonts 
by time-lapse video microscopy. As shown in Fig 4C and movie S2, 
PfICM1-null schizonts exhibited an abnormal phenotype, with either 
complete loss of egress or rounding up with increased intracellular 
merozoite mobility (indicative of parasitophorous vacuole membrane 
rupture (40)) but no obvious rupture of the RBC membrane, with very 
few merozoites escaping the confines of the RBC. Quantification of 
the videos showed fewer egress events and a significant delay in time 
to egress for the PfICM1-null parasites (Fig. 4, D and E). No examples 
were observed of the explosive egress typical of WT parasites, although 
following prolonged incubation free PfICM1-null merozoites were 
visible (Fig. 4B and fig. S6A). To further characterize the phenotype, 
we compared egress of both DMSO- and RAP- treated pfpkg:cKO and 
pficm1:cKO schizonts by monitoring the appearance in culture super-
natants of the parasitophorous vacuole protein Serine Repeat Antigen 5 
(SERA5). No release of SERA5 occurred in cultures of PfPKG-null 
parasites, while in marked contrast processed SERA5 appeared in 
the medium of PfICM1-null parasites, albeit with a delay compared to 
DMSO-treated parasites (fig. S6, B and C). Because proteolytic pro-
cessing of SERA5 requires discharge of the protease SUB1 from ex-
onemes (41), this result suggests that protein discharge from these 
secretory organelles is not affected by loss of ICM1. No differences 
in cellular cGMP levels were detectable in DMSO- and RAP-treated 
pficm1:cKO parasites (Fig. 4F). Collectively, these results suggested a 
role for PfICM1 in egress downstream of PKG activation.
Given the loss of long-term viability in static cultures of PfICM1-
null parasites, we addressed whether the egress defect could be over-
come by mechanical shear stress. As shown in Fig. 4G, even under 
shaking conditions, production of new rings was severely compro-
mised in RAP-treated pficm1:cKO cultures. This prompted us to ex-
amine release of other secretory organelle proteins and in particular 
of AMA1, an essential invasion protein that translocates from micronemes 
to the surface of daughter merozoites at or just before the point of egress 
(42). As shown in Fig. 4H, comparative IFA revealed a severe defect 
in AMA1 discharge in the PfICM1-null schizonts. It was concluded that 
this likely explains the loss of invasion in the PfICM1-null parasites.
Release of micronemal contents has been linked to a calcium sig-
naling pathway essential for egress and invasion, involving at least 
one calcium-dependent protein kinase, PfCDPK5 (43). To address 
the question of whether loss of ICM1 leads to a defect in calcium 
mobilization, we used the PDE inhibitor zaprinast to artificially ac-
tivate PKG by prematurely increasing cGMP levels, forcing a PKG- 
dependent increase in cytosolic calcium levels (8). Addition of DMSO 
(vehicle control) to both WT and PfICM1-null parasites showed no 
increase in calcium levels (Fig. 4I). Calcium levels in PfICM1-null 
parasites exposed to zaprinast were significantly reduced compared 
to controls, similar to our findings with Pama1ICM1 gametocytes. In 
contrast, treatment with the calcium ionophore A23187 had similar 
effects in both DMSO- and RAP-treated pficm1:cKO schizonts, sug-
gesting that intracellular calcium levels are unaffected by loss of 
ICM1 (Fig. 4, J and K). Our results indicate that PfICM1 is involved 
in downstream transduction of calcium signals essential for egress 
and invasion in asexual blood stages.
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PfICM1 and PfPKG-dependent phosphoproteomes suggest 
functional overlap in schizonts
Given the physical interaction between ICM1 and PKG in P. falciparum 
schizonts and their roles in calcium mobilization, we further ex-
plored the functional link between the two proteins by determining 
the impact of ICM1 depletion on the global schizont phosphopro-
teome. We reasoned that if ICM1 acts downstream of PKG and if its 
function is regulated directly or indirectly by PKG-dependent phos-
phorylation, then an overlap would be expected between the two 
phosphoproteomes.
Fig. 4. PfICM1 is essential for parasite viability, microneme discharge, efficient egress, and invasion. (A) Replication of DMSO- and RAP-treated pficm1:cKO parasites 
(n = 3). (B) Giemsa-stained blood films showing normal development of DMSO- and RAP-treated pficm1:cKO schizonts 46 hours after treatment. By 50 hours, most control 
parasites had successfully invaded while very few rings formed in RAP-treated cultures. (C) Stills from time-lapse differential inference contrast (DIC) video microscopy 
of DMSO/RAP-treated pficm1:cKO schizonts. (D) Egress quantification of DMSO- and RAP-treated pficm1:cKO schizonts. (n = 4). P value derived from paired t tests. 
(E) Quantification of time to egress for each schizont. P value, unpaired two-tailed t test (DMSO, 209 schizonts; RAP, 55 schizonts). Error bars, ±SD. (F) cGMP levels in 
DMSO- and RAP-treated pficm1:cKO schizonts (n = 2). P value, paired t test. (G) Invasion assays of DMSO- and RAP-treated pficm1:cKO schizonts. P values, paired t test. 
(H) Left: Representative IFA images of pficm1:cKO parasites showing translocated AMA1 in DMSO-treated or micronemal AMA1 in RAP-treated merozoites. Right: Quanti-
fication of AMA1 relocalization (n = 3). At least 150 schizonts were quantified in each. Values, means ± SD. (I to K) Relative Fluo-4 AM fluorescence response of DMSO- and 
RAP-treated pficm1:cKO schizonts after treatment with DMSO, zaprinast, or A21387 (n = 4). For the AUC, DMSO values were normalized to 1. Values, means ± SD. P values, 
two tailed t test.
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Using an approach similar to that previously used for PfPKG, we 
identified 106 phosphosites from 75 proteins that are significantly 
hypophosphorylated upon disruption of PfICM1 (Fig. 5A and data 
S4). Proteins involved in cyclic nucleotide-dependent signaling cas-
cades were among this set, including adenylyl cyclase beta (AC), 
GC, and CDPK1. Motif analysis of the hypophosphorylated phospho-
peptides showed a strict preference for lysine in position −3, resem-
bling a minimal cAMP-dependent protein kinase (PKA)/PKG 
recognition motif (KxxpS/pT) (Fig. 5B). A similar substrate prefer-
ence was also described in a recent study on the impact of CDPK5 
depletion on the schizont phosphoproteome (44). GO term enrich-
ment analysis of this set of 75 proteins showed deregulation of 
cyclic nucleotide biosynthesis, ATPase activity and RNA splicing 
(GO:0000375), as also observed in the PfPKG phosphoproteome 
(Fig. 5C and data S4). Comparison of the two phosphoproteome 
sets identified 73 phosphosites in 67 proteins that are regulated by 
both PKG and ICM1 in schizonts (Fig. 5D and data S4). These in-
clude proteins involved in signaling as well as in egress and invasion, 
such as CDPK1, DGK1 (diacylglycerol kinase), AC, RhopH3 (high 
molecular weight rhoptry protein 3), and AMA1 (apical membrane 
antigen 1). Collectively, these data strongly support a functional link 
between the essential roles of PKG and ICM1.
DISCUSSION
Many genetic and chemical genetic studies have shown a clear re-
quirement for PKG in specific calcium signals or calcium-dependent 
pathways (7, 8, 10, 41, 43), but the molecular partners involved in 
calcium mobilization have remained elusive (3). Here, we have iden-
tified ICM1 as a tightly associated PKG partner protein that plays a 
key role in calcium signals in both schizonts and gametocytes. Our 
data suggest that ICM1 mainly acts downstream of PKG, because 
Fig. 5. Impact of PfICM1 disruption on the schizont phosphoproteome. (A) Volcano plot showing distribution of phosphopeptide abundance in the presence or ab-
sence of PfICM1. Red circles correspond to significantly down-regulated peptides and blue circles to significantly up-regulated peptides. A cutoff of Welch difference 
of <−0.875 and >0.875 with P <0.05 and a localization probability of >0.7 represent significantly regulated peptides. (B) Motif analysis of the significantly down-regulated 
phosphosites in PfICM1-null parasites. All detected phosphopeptides were used as the reference dataset, with amino acids below the position line indicating residues 
unfavored for this position. Position 0 corresponds to the phosphorylated residue. (C) GO enrichment analysis of biological process and molecular function for proteins 
significantly hypophosphorylated in PfICM1-null parasites. Enriched terms with P < 0.01 are shown. (D) Venn diagram showing the number of phosphoproteins and the 
corresponding phosphopeptides significantly deregulated by PfPKG and PfICM1.
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ICM1 does not seem to be required for calcium homeostasis during 
intraerythrocytic development but only for PKG-mediated calcium 
signals leading to egress and activation of gametogenesis. This sug-
gests a temporally restricted role in calcium homeostasis across the 
Plasmodium life cycle. Future experiments will be needed to deter-
mine the impact of ICM1 ablation on CDPK activation in both asexual 
and sexual stages. Two putative orthologs of icm1 are predicted in 
Toxoplasma gondii, a related apicomplexan parasite, which also re-
lies on PKG-dependent calcium signals upstream of CDPKs to con-
trol egress, motility, and invasion. Could ICM1 be the long-sought 
Plasmodium IP3 receptor or could it act as a calcium channel? Our 
modeling data suggest that ICM1 resembles a channel but the low 
amino acid sequence similarity indicates that if it is a calcium channel, 
then it is highly divergent from other well-studied calcium channels. 
ICM1 could possibly represent an evolutionary alternative pathway 
functionally replacing the IP3-R and the associated IRAG proteins 
that bridge PKG and calcium in human cells. Recombinant and/or 
heterologous expression and biophysical analysis will be needed to 
evaluate the function of ICM1 as a calcium channel and to investi-
gate its regulation by IP3, other secondary messengers or even by 
PKG-dependent phosphorylation.
Interactions between kinases and other proteins are a common 
signaling mechanism, with the A-kinase anchoring proteins that 
bind to PKA or the mitogen-activated protein kinase scaffolding 
proteins being some of the best studied examples (45, 46). In con-
trast, little is known about proteins interacting with PKG in eukaryotes 
as few partners have been identified (13, 47–49). In Plasmodium, 
the only previous data available for a PKG-interacting protein came 
from an in vitro study using the kinase domain of PKG (50), while 
a putative interaction between PKG and ICM1 was detected in a 
very recent elegant study profiling a potent inhibitor of PKG. How-
ever, conditional knockdown of ICM1 in that work resulted only in 
a minor growth defect, perhaps due to the different conditional sys-
tem used (51), the TetR-DOZI aptamer system, which may require 
more than one cycle to achieve efficient down-regulation (52). The 
phenotype observed in our study could be a consequence of the 
high efficiency of gene disruption obtained with the DiCre system, 
combined with the fact that gene disruption is at the genomic rather 
than the transcriptional level.
Our identification of the PKG-ICM1 interaction creates new and 
exciting questions regarding calcium homeostasis in apicomplexan 
parasites and further strengthens the notion that calcium regulation 
in this phylum could be regulated by a class of divergent channels.
MATERIALS AND METHODS
Ethics statement
All animal experiments were conducted with the authorization num-
bers GE/82/15 and GE/41/17, according to the guidelines and regu-
lations issued by the Swiss Federal Veterinary Office.
Reagents
WR99210 was from Jacobus Pharmaceuticals (New Jersey, USA). 
RAP was from Sigma-Aldrich and used at 20 nM. The PKG inhibitors 
compound 2 (4-[7-[(dimethylamino)methyl]-2-(4-fluorphenyl)im-
idazol[1,2-]pyridine-3-yl]pyrimidin-2-amine) and compound A 
(1,4-cyclohexanediamine, N-[3-[2-[(3-fluoro-2-pyridinyl)amino]-5- 
pyrimidinyl]imidazo[1,2-b]pyridazin-6-yl], trans-) were stored as a 
10 mM stock in DMSO at −20°C, while working dilution was 1 M. The 
calcium ionophore A23187 and zaprinast were both from Sigma- 
Aldrich and used at 10 and 100 M, respectively.
P. falciparum culture, transfection, and synchronization
All P. falciparum lines were maintained at 37°C in human RBCs in 
RPMI 1640 containing AlbuMAX II (Thermo Fisher Scientific), 
and medium was supplemented with 2 mM l-glutamine. Parasite 
synchronization and transfections were performed as previously de-
scribed (53). Clonal lines were obtained by serial limiting dilution 
in flat bottomed 96-well plates, and single plaques were selected and 
grown in the presence of 1 M 5-fluorocytosine (provided as clini-
cal grade Ancotyl) to select for Cas9 plasmid-free and marker-free 
parasites. For parasite genomic DNA (gDNA) extraction, the Qiagen 
DNeasy Blood and Tissue kit was used. Genotype analysis PCR was done 
using Phusion polymerase (New England Biolabs). For P. falciparum 
experiments, DiCre activity was induced by RAP treatment of early 
rings (2 to 3 hours after invasion) as previously described (54). Samples 
for excision PCRs were collected 24 hours after RAP treatment.
P. berghei maintenance, purification, and transfection
P. berghei maintenance, purification, and transfection were performed 
as previously described (21). P. berghei ANKA strain (36) derived 
clones 2.34 (27) and 615 (35), together with derived transgenic lines, 
were grown and maintained in CD1 outbred mice. Six- to 10-week-old 
mice were obtained from Charles River Laboratories, and females were 
used for all experiments. Mice were specific pathogen free (includ-
ing Mycoplasma pulmonis) and subjected to regular pathogen moni-
toring by sentinel screening. They were housed in individually 
ventilated cages furnished with a cardboard mouse house and Nestlet, 
maintained at 21° ± 2°C under a 12-hour light/dark cycle, and given 
commercially prepared autoclaved dry rodent diet and water ad 
libitum. The parasitemia of infected animals was determined by 
microscopy of methanol-fixed Giemsa-stained thin blood smears.
For gametocyte production, parasites were grown in mice that had 
been phenyl hydrazine-treated 3 days before infection. One day after 
infection, sulfadiazine (20 mg/liter) was added in the drinking water 
to eliminate asexually replicating parasites. Microgametocyte ex-
flagellation was measured 3 or 4 days after infection by adding 4 l 
of blood from a superficial tail vein to 70 l of exflagellation medium 
[RPMI 1640 containing 25 mM Hepes, 4 mM sodium bicarbonate, 
5% fetal calf serum (FCS), and 100 M XA (pH 7.4)]. To calculate 
the number of exflagellation centers per 100 microgametocytes, the 
percentage of RBCs infected with microgametocytes was assessed on 
Giemsa-stained smears. For gametocyte purification, parasites were 
harvested in suspended animation (SA) medium [RPMI 1640 contain-
ing 25 mM Hepes, 5% FCS, and 4 mM sodium bicarbonate (pH 7.20)] 
and separated from uninfected RBCs on a Histodenz (Sigma-Aldrich) 
cushion made from 48% of a Histodenz stock [27.6% (w/v) Histodenz 
in 5.0 mM tris-HCl, 3.0 mM KCl, and 0.3 mM EDTA (pH 7.20)] 
and 52% SA (final pH 7.2). Gametocytes were harvested from the 
interface. To induce ICM1-AID/HA degradation, 1 mM auxin dis-
solved in ethanol was added to purified gametocytes for 1 hour.
Schizonts for transfection were purified from overnight in vitro 
culture on a Histodenz cushion made from 55% of the Histodenz 
stock and 45% phosphate-buffered saline (PBS). Parasites were har-
vested from the interface and collected by centrifugation at 500g for 
3 min, resuspended in 25 l of Amaxa Basic Parasite Nucleofector 
solution (Lonza), and added to 10 to 20 g of DNA dissolved in 
10 l of H2O. Cells were electroporated using the FI-115 program of 
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the Amaxa Nucleofector 4D. Transfected parasites were resuspended 
in 200 l of fresh RBCs and injected intraperitoneally into mice. 
Parasite selection with pyrimethamine (0.07 mg/ml; Sigma-Aldrich) 
in the drinking water (pH ~4.5) was initiated 1 day after infection.
Plasmid construction and genotyping of P. falciparum 
transgenic lines
Oligonucleotides used in this study are shown in table S1. To create 
line PKG-GFP, the triple HA tag from plasmid pHH1-PfPKG-HA 
(17) was replaced by enhanced GFP (eGFP). Briefly, eGFP was 
PCR-amplified from plasmid pBAT-SIL6 (55) using primers GFP_
For and GFP_Rev. The PCR product was digested with Avr II and 
Xho I and ligated to vector pHH1-PfPKG-HA previously digested with 
the same enzymes. Plasmid was transfected into 3D7 P. falciparum, 
and growth medium was replaced 24 hours after transfection with 
fresh medium containing 2.5 nM WR99210. Parasites were subjected 
to culture in the absence of WR99210 (3 cycles) followed by cultur-
ing with drug to select for transgenic parasites. Clonal lines were 
confirmed by PCR using primers wtpkg_For and 3utr_Rev and main-
tained in the presence of WR99210.
The DiCre-expressing B11 line (39) was used to generate line 
icm:cKO in two steps. The first step aimed at modifying the 3′ end 
of the gene. To achieve that, a commercially obtained construct 
(GeneArt, Thermo Fisher Scientific) contained in tandem: (i) a 5′ 
homology arm of 456–base pair (bp) endogenous and 255 bp of 
synthetic sequence comprising the 3′ end of exon 2 and the whole of 
exon 3; (ii) a fragment comprising a triple HA tag, loxN, and the 3′ 
46 bp of the sera2 intron; and lastly, (iii) the first 408 bp of pficm1 3′ 
untranslated region (3′UTR) as a 3′ homology arm. This plasmid 
(pMX_icm1-int) was digested with Sal I/Sac I and a T2A peptide fol-
lowed by a GFP gene (fragment obtained from plasmid pT2A_D1_
cKO, a gift from E. Deu) was cloned in after the 3′ end of the sera2 
intron, resulting in plasmid pMX_icm1_2. A single guide RNA 
(sgRNA) targeting sequence TTGATTAAATAAATATATAA was 
inserted into a previously described pDC2 plasmid expressing Cas9, 
resulting in plasmid pDC2-icm1_2g. The repair plasmid (pMX_
icm1_2) was linearized overnight with Bgl II and transfected in B11 
parasites together with plasmid pDC2_icm1_2g. Integration was 
confirmed by PCR, using primer pairs L2_For/L2_Rev and L2_For/
L2_HA. This clonal line (icm1:HA) was obtained via limiting dilu-
tion and was used for the second modification step, which involved 
replacing the endogenous intron 1 with the 2loxPint module (5). A 
commercially obtained construct (GeneArt, Thermo Fisher Scientific) 
was used (pMX_icm1_2loxPint), containing the 2loxPint module 
flanked by approximately 400 bp of endogenous sequence as homol-
ogy arms. This vector was linearized with Bgl II and cotransfected 
with a pDC2-based Cas9 plasmid (56), harboring the sgRNA target-
ing sequence ATTTCAAAGGACTTACTTTA, in line icm1_HA. 
Clonal lines were obtained as described above, and integration was 
confirmed using primer pairs L1_For/L1_Rev.
To create a conditional KO of PfPKG, vector pDC_loxnPKG: 
lox22mCherry was digested with Xba I and Nhe I. The latter restric-
tion site was blunted and the vector was religated resulting in vector 
pDC_lox22mCherry. This plasmid was linearized overnight with 
Sca I and transfected together with the pDC2-pkg Cas9 plasmid into 
P. falciparum line pfpkg_2lox (5). Correct 5′ and 3′ integration were 
verified by PCR using primers wtpkg_For/5int_Rev. The absence 
of the endogenous locus was confirmed using primers exon1_For/
PKGutr_Rev.
Plasmid construction and genotyping of P. berghei 
transgenic lines
The oligonucleotides used to generate and genotype the mutant par-
asite lines are in table S1.
Restriction/ligation cloning
To generate the Pama1ICM1 line, the plasmid pOB116-ama1 was 
used (36). The first 1000 bp from PbICM1 gene was amplified from 
gDNA using the primers 453 and 458. The PCR product was digest-
ed with Xho I and Not I and ligated into the pOB116-ama1 plasmid 
previously digested with the same enzymes, resulting in the plasmid 
pAB025. The last 750 bp of PbICM1 5′UTR were amplified using 
primers 459 and 464, and the resulting fragment was digested with 
Hind III and Pst I and ligated into pAB026 previously digested with 
the same enzymes. The same strategy was used to generate the line 
Pclag9ICM1, with the plasmid pOB116-clag9 resulting in plasmid 
pAB027. Both plasmids were digested with the enzymes Eco RV and 
Hind III to be transfected in P. berghei.
Recombineering
ICM1-HA3 and ICM1-AID/HA tagging constructs were generated 
using phage recombineering in Escherichia coli TSA strain with 
PlasmoGEM vectors (http://plasmogem.sanger.ac.uk/) as previously 
described (33, 34). The modified library inserts were then released 
from the plasmid backbone using Not I. The ICM1-AID/HA (PbGEM- 
645751) targeting vector was transfected into the 615 line (35). The 
ICM1-HA3 (PbGEM-121338) and ICM1-KO (PbGEM-265644) vec-
tors were transfected into the 2.34 line.
Each mutant parasite was genotyped by PCR using three combi-
nations of primers, specific for either the WT or the modified locus 
on both sides of the targeted region (experimental designs are shown 
in figs. S1 and S4). Controls using WT DNA were included in each 
genotyping experiment; parasite lines were cloned when indicated.
P. falciparum growth assays
Growth rates in P. falciparum mutant lines were performed as fol-
lows: synchronous ring-stage parasites at 0.1% parasitemia and 2% 
hematocrit were dispensed in triplicate into 12-well plates. Samples 
(50 l) from each well were collected at 0, 2, 4, and 6 days, stained 
with SYBR green, and analyzed by flow cytometry on a BD FACSVerse 
using BD FACSuite software. Data acquired were analyzed using 
FlowJo software.
P. falciparum egress and invasion assays
Mature schizonts were isolated by Percoll centrifugation and incu-
bated for a further 3 hours in complete medium containing the revers-
ible PKG inhibitor compound 2 (1 M). After removal of the inhibitor, 
schizonts were immediately resuspended in fresh serum-free RPMI 1640 
at 37°C to allow egress. Schizont pellets and culture supernatants at 
t = 0 were collected as a control sample, while culture supernatants 
were collected by centrifugation at the relevant time points.
For invasion assays, mature schizonts were incubated at 2 to 4% 
parasitemia in 2% hematocrit under static or shaking conditions for 
4 hours. Unruptured schizonts were removed by Percoll gradient, par-
asitemia was measured again, and the fold increase was calculated.
Calcium measurements
P. falciparum schizonts
Changes in calcium levels were measured using Fluo-4 acetoxymethyl 
ester (AM)–loaded (Thermo Fisher Scientific) parasites, and differ-
ences in fluorescence were measured over time on a BD FACSVerse 
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flow cytometer using BD FACSuite software. Briefly, schizonts were 
washed twice in phenol red– and serum-free RPMI medium (11835030, 
Thermo Fisher Scientific). Fluo-4 AM (5 M) was added to 1 ml of 
parasite preparation. Cells were incubated with Fluo-4 AM at 37°C 
for 45 min and washed twice in phenol red– and serum-free RPMI 
as above. Parasites were incubated for 30 min for deesterification 
followed by a further two washes. Schizonts were resuspended in 
1 ml of warm phenol red– and serum-free RPMI. For Fluo-4 AM 
detection a 488-nm Blue Laser was used with a 530/30 filter. Fluo-
rescence levels were measured for a period of 90 s to obtain a base-
line read. Compounds were then added onto the cells, and reads 
were recorded for a further 3  min. Data analysis was done with 
FlowJo software.
P. berghei gametocytes
To measure changes in the calcium level, P. berghei gametocytes were 
harvested in coelenterazine loading buffer (29) [CLB; PBS contain-
ing 20 mM Hepes, 20 mM glucose, 4 mM NaHCO3, 1 mM EDTA, 
and 0.1% bovine serum albumin (BSA) (pH 7.2)]. Gametocytes were 
purified as described above and resuspended in 1 ml of CLB and load-
ed with 5 M of Fluo-4 AM for an hour. The parasites were then 
washed twice with CLB and resuspended in 500 l, and 20 l was 
added per well in a 96-well plate. Compound dispense and simulta-
neous fluorescence reading were performed by a FDSS/CELL 
(Hamamatsu Photonics) for a period of 5 min. The fluorescence val-
ue of each time point was first normalized to the initial fluorescence 
value at 0 s (Ft = n/Ft = 0) and then by the vehicle control (Ft = n/
Ft = 0)/(Fvehicle t = n/Fvehicle t = 0).
Flow cytometry analysis of gametocytes
To analyze their DNA content, gametocytes were harvested in SA 
and purified as described above. Gametocytes were resuspended in 
100 l and activated with 100 l of modified exflagellation medium 
[RPMI 1640 containing 25 mM Hepes, 4 mM sodium bicarbonate, 
5% FCS, and 200 M XA (pH 8.0)]. Gametogenesis was stopped by 
ice-cold PBS containing Vybrant dye cycle violet (Life Technologies), 
and cells were stained for 30 min at 4°C. DNA content was deter-
mined using a Beckman Coulter Gallios 4 and analyzed with the 
Kaluza software. Per sample, >10,000 cells were analyzed.
Immunoblotting and immunofluorescence assays
P. falciparum
Synchronized P. falciparum schizonts were isolated by Percoll gra-
dient centrifugation and washed in RPMI 1640 without Albumax. 
Parasites were extracted into a Triton X-100 buffer [20 mM tris-HCl 
(pH 7.4), 150 mM NaCl, 0.5 mM EDTA, and 1% Triton X-100, sup-
plemented with 1× protease inhibitors, Roche]. Extracts were incu-
bated on ice for 30 min then clarified by centrifugation at 12,000g 
for 15 min at 4°C. Supernatants were mixed with SDS sample buffer 
containing dithiothreitol (DTT) and incubated for 5 min at 95°C be-
fore fractionation by SDS-PAGE analysis on 4 to 15% Mini-PROTEAN 
TGX Stain-Free Protein Gels (Bio-Rad). Transfer to nitrocellulose 
membranes and probing for Western blot analysis were as described 
previously. A rabbit polyclonal human-PKG antibody (Enzo Life 
Sciences) was used for PKG detection at 1:1000. A GFP-specific 
monoclonal antibody 11814460001 (Roche) was used at 1:1000, as 
was a polyclonal rabbit anti-mCherry (ab167453; Abcam). A poly-
clonal rabbit anti-SERA5 antibody was used at 1:2000, and an anti- 
HSP70 antibody (a gift from E. Knuepfer, Francis Crick Institute) 
was used at 1:2000.
For IFA analysis, thin blood smears of wt, pficm1:cKO DMSO-, 
and RAP-treated Percoll-enriched schizonts were fixed in 4% (w/v) 
paraformaldehyde and permeabilized in 0.1% (v/v) Triton X-100. Af-
ter blocking with 3% BSA, smears were probed with a rat anti-HA 
(3F10; 1:100) and a rabbit anti-SERA5 (1:500). For AMA1 relocal-
ization, vehicle (DMSO) or RAP-treated Percoll-enriched pficm1:cKO 
schizonts were probed with a rabbit anti-AMA1 (1:200). Subsequently, 
slides were probed with the required Alexa Fluor 594–conjugated 
secondary antibody diluted (1:1000). Images were collected using a 
Nikon Eclipse Ni-E wide-field microscope with a Hamamatsu C11440 
digital camera and 100×/1.45 numerical aperture (NA) oil immer-
sion objective. Identical exposure conditions were used at each 
wavelength for each pair of mock- and RAP-treated samples under 
comparison. Images were processed using Fiji software (57).
P. berghei
Gametocyte immunofluorescence assays were performed as previ-
ously described (58). For HA and -tubulin staining, purified cells 
were fixed with 4% paraformaldehyde and 0.05% glutaraldehyde in 
PBS for 1 hour, permeabilized with 0.1% Triton X-100/PBS for 10 min, 
and blocked with 2% BSA/PBS for 2 hours. Primary antibodies were 
diluted in blocking solution (rat anti-HA clone, 3F10, 1:1000; mouse 
anti–-tubulin clone, DM1A, 1:1000; both from Sigma-Aldrich). 
Anti-rat Alexa 594, anti-mouse Alexa 488, anti-rabbit Alexa 488, and 
anti-rabbit Alexa 594 were used as secondary antibodies together 
with DAPI (4′,6-diamidino-2-phenylindole) (all from Life Technol-
ogies), all diluted at 1:1000  in blocking solution. Confocal images 
were acquired with a LSM700 or a LSM800 scanning confocal mi-
croscope (Zeiss).
Time-lapse and live fluorescence microscopy
Viewing chambers were constructed as previously described (41). 
Images were recorded on a Nikon Eclipse Ni light microscope fitted 
with a Hamamatsu C11440 digital camera and Nikon N Plan Apo  
63×/1.45 NA oil immersion objective. For time-lapse video micros-
copy, vehicle (DMSO) or RAP-treated schizonts were synchronized 
by incubation with the reversible PKG inhibitor compound 2 and 
then washed, mixed in equal proportions, and monitored for egress. 
Differential inference contrast (DIC) images were taken at 10-s in-
tervals over 45 min, while fluorescence (GFP or mCherry) images 
were taken every 5 to 10 min to prevent bleaching. Time-lapse vid-
eos were analyzed and annotated using Fiji (57).
Measurement of intracellular cyclic nucleotide levels
Relative intracellular cGMP levels in mature schizonts were measured 
using the Direct cGMP ELISA kit (Enzo). RAP- or DMSO-treated 
icm1:cKO schizonts were Percoll-purified and lysed in the presence 
of 0.1 ml of 0.1 M HCl to harvest cGMP. Samples were incubated at 
room temperature for 5 min with intermittent vortexing. Standards 
were fitted to a sigmoidal curve and used to determine cyclic nucle-
otide concentrations in parasite samples.
ICM1 protein structure prediction
The homology models of PfICM1 were constructed initially using 
the Phyre2 Server in intensive mode (22). The I-TASSER meta- 
threading procedure (https://zhanglab.ccmb.med.umich.edu/
I-TASSER/) was run to generate a molecular model of PfICM1, using 
the first 1500 amino acids of the protein (I-TASSER maximum al-
lowed residues) and covering domains of the protein predicted to 
be highly helical (59–61). The local Meta-Threader Server identified 
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PDB 6MU1, 6JXC, 6RLB, and 6C08 as the top four threading tem-
plates for protein structure prediction, three of them being trans-
porter proteins.
IP and MS analysis in P. falciparum
For pull-down analysis, frozen schizont preparations from lines 
PfPKG-HA, PKG-GFP, and 3D7 were resuspended in 100 l of lysis 
buffer [20 mM tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, and 
1% Triton X-100, complete protease inhibitors and PhosSTOP] and 
extracted at 4°C for 30 min with intermittent vortexing. Extracts 
were clarified by centrifugation at 16,000g for 20 min at 4°C, filtered 
through 0.22 Corning Costar Spin-X centrifuge tube filters, and 
then incubated with 25 l of anti-HA magnetic beads (Pierce) or 
with 25 l of GFP-Trap Magnetic Agarose (ChromoTek) overnight 
at 4°C. Sample processing followed the manufacturer’s protocol. 
Protein complexes were eluted from beads with the addition of 2× 
volumes of reduced 2× SDS sample buffer. Samples were incubated 
at 95°C for 5 min and run on 12% SDS-PAGE gels. Band slices cov-
ering the whole separation profile were excised and washed. Reduced 
and alkylated proteins were in-gel digested with 100 ng of trypsin 
(modified sequencing grade, Promega) overnight at 37°C. Superna-
tants were dried in a vacuum centrifuge and resuspended in 0.1% 
trifluoroacetic acid (TFA). Digested protein (1 to 10 l) acidified to 
a final concentration of 0.1% TFA was loaded on an UltiMate 3000 
nanoRSLC HPLC (Thermo Fisher Scientific) at 15 l/min of 0.1% 
TFA onto a 2 mm by 0.3 mm Acclaim PepMap C18 trap column 
(Thermo Fisher Scientific) before the trap being switched to elute at 
0.25 l/min through a 50 cm by 75 m EASY-Spray C18 column. A 
90′ gradient of 9 to 25% B over 37′ and then 25 to 40% B over 18′ 
was used followed by a short gradient to 100% B and back down to 
9% B and a 20′ equilibration in 9% B [A = 2% acetonitrile (ACN), 
0.1% formic acid (FA); B = 80% ACN, 0.1% FA].
The Orbitrap was operated in “Data Dependent Acquisition” mode 
with a survey scan at a resolution of 120,000 from mass/charge ratio 
(m/z) of 300 to 1500, followed by MS/MS in “TopS” mode. Dynamic 
exclusion was used with a time window of 20 s. The Orbitrap charge 
capacity was set to a maximum of 1 × 106 ions in 10 ms, while the 
LTQ was set to 1 × 104 ions in 100 ms. Raw files were processed 
using MaxQuant 1.3.0.5 and Perseus 1.4.0.11 against a recent ver-
sion of PlasmoDB (www.plasmodb.org). A decoy database of re-
versed sequences was used to filter false positives, at a peptide false 
detection rate of 1%.
IP and MS analysis in P. berghei
Sample preparation
Co-IPs of proteins were performed with purified gametocytes. The 
following IPs were performed: ICM1-HA3 in schizonts or gameto-
cytes (15 s post activation +/− compound A) and PKG-HA3 in schizonts 
or gametocytes (15 s post activation +/− compound A). IPs from WT 
nonactivated gametocytes lacking an epitope tag were used as controls.
Samples were fixed for 10 min with 1% formaldehyde. Parasites 
were lysed in RIPA buffer [50 mM tris-HCl (pH 8), 150 mM NaCl, 
1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS], and the su-
pernatant was subjected to affinity purification with anti-HA anti-
body (Sigma-Aldrich) conjugated to magnetics beads. Beads were 
resuspended in 100 l of 6 M urea in 50 mM ammonium bicarbonate 
(AB). Two microliters of 50 mM dithioerythritol (DTE) were add-
ed, and the reduction was carried out at 37°C for 1 hour. Alkylation 
was performed by adding 2 l of 400 mM iodoacetamide for 1 hour 
at room temperature in the dark. Urea was reduced to 1 M by addi-
tion of 500 l of AB, and overnight digestion was performed at 37°C 
with 5 l of freshly prepared trypsin (0.2 g/l; Promega) in AB. Super-
natants were collected and completely dried under speed vacuum. 
Samples were then desalted with a C18 microspin column (Harvard 
Apparatus) according to the manufacturer’s instructions, completely 
dried under speed vacuum, and stored at −20°C.
Liquid chromatography electrospray ionization tandem  
mass spectrometry
Samples were diluted in 20 l of loading buffer [5% acetonitrile (AcN) 
(CH3CN) and 0.1% FA], and 2 l was injected onto the column. Liquid 
chromatography electrospray ionization tandem mass spectrometry 
(LC-ESI-MS/MS) was performed either on a Q-Exactive Plus Hybrid 
Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific) 
equipped with an Easy nLC 1000 liquid chromatography system 
(Thermo Fisher Scientific) or an Orbitrap Fusion Lumos Tribrid Mass 
Spectrometer (Thermo Fisher Scientific) equipped with an Easy nLC 
1200 liquid chromatography system (Thermo Fisher Scientific). 
Peptides were trapped on an Acclaim PepMap 100, 3-m C18, 75 m 
by 20 mm nano-trap column (Thermo Fisher Scientific) and sepa-
rated on a 75 m by 250 mm (Q-Exactive) or 500 mm (Orbitrap Fusion 
Lumos), 2-m C18, 100 Å EASY-Spray column (Thermo Fisher Sci-
entific). The analytical separation used a gradient of H2O/0.1% FA 
(solvent A) and CH3CN/0.1% FA (solvent B). The gradient was run 
as follows: 95% A and 5% B for 0 to 5 min, then to 65% A and 35% 
B for 60 min, then to 10% A and 90% B for 10 min, and lastly to 10% 
A and 90% B for 15 min. Flow rate was 250 nl/min for a total run 
time of 90 min.
Data-dependent analysis (DDA) was performed on the Q-Exactive 
Plus with MS1 full scan at a resolution of 70,000 full width at half 
maximum (FWHM) followed by MS2 scans on up to 15 selected 
precursors. MS1 was performed with an automatic gain control 
(AGC) target of 3 × 106, a maximum injection time of 100 ms, and 
a scan range from 400 to 2000 m/z. MS2 was performed at a resolu-
tion of 17,500 FWHM with an AGC target at 1 × 105 and a maxi-
mum injection time of 50 ms. Isolation window was set at 1.6 m/z, 
and 27% normalized collision energy was used for higher-energy 
collisional dissociation (HCD). DDA was performed on the Orbitrap 
Fusion Lumos with MS1 full scan at a resolution of 120,000 FWHM 
followed by as many subsequent MS2 scans on selected precursors 
as possible within a 3-s maximum cycle time. MS1 was performed 
in the Orbitrap with an AGC target of 4 × 105, a maximum injection 
time of 50 ms, and a scan range from 400 to 2000 m/z. MS2 was 
performed in the ion trap with a rapid scan rate, an AGC target of 
1 × 104, and a maximum injection time of 35 ms. Isolation window 
was set at 1.2 m/z, and 30% normalized collision energy was used 
for HCD.
Database searches
Peak lists (MGF file format) were generated from raw data using the 
MS Convert conversion tool from ProteoWizard. The peak list files 
were searched against the PlasmoDB_P.berghei ANKA database 
(PlasmoDB.org, release 38, 5076 entries) combined with an in-house 
database of common contaminants using Mascot (Matrix Science, 
London, UK; version 2.5.1). Trypsin was selected as the enzyme, 
with one potential missed cleavage. Precursor ion tolerance was set 
to 10 parts per million (ppm) and fragment ion tolerance to 0.02 Da 
for Q-Exactive Plus data and to 0.6 for Lumos data. Variable amino 
acid modifications were oxidized methionine and deamination (as-
paragine and glutamine) as well as phosphorylated serine, threonine, 
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and tyrosine. Fixed amino acid modification was carbamidomethyl 
cysteine. The Mascot search was validated using Scaffold 4.8.4 (Pro-
teome Software) with 1% of protein false discovery rate (FDR) and 
at least two unique peptides per protein with a 0.1% peptide FDR.
PCA analysis
Enrichment and PCA were performed in the statistical programming 
package “R” (www.r-project.org). Quantitative values were analyzed 
as log-transformed spectral count values and displayed in principal 
components with greatest degrees of variance.
Chemoproteomics
Kinobeads were prepared as described (62, 63). The chemoproteomic 
affinity capturing experiments were performed as previously described 
(62, 64). Briefly, Kinobeads were incubated with P. falciparum 
extract (65), which was preincubated with compound or DMSO 
(vehicle control). The experimental setup was such that 10 samples 
are measured in parallel [TMT 10-plex (66)] to generate values for 
the affinity of the beads to the bound proteins (“depletion” values, 
four samples) and to generate median inhibitory concentration 
values based on dose-dependent competition (six samples, 20 M, 
1:3 dilutions) in a single experiment. Beads were transferred to 
Filter plates (Durapore polyvinylidene difluoride membrane, 
Merck Millipore), washed extensively, and eluted with SDS sample 
buffer (67).
Proteins were digested according to a modified single pot solid- 
phase sample preparation (SP3) protocol (68, 69). Proteins were 
digested by resuspending in 0.1 mM Hepes (pH 8.5) containing 
tris(2-carboxyethyl)phosphine (TCEP), chloracetamide, trypsin, and 
LysC following overnight incubation.
Peptides were labeled with isobaric mass tags (TMT10, Thermo 
Fisher Scientific, Waltham, MA) using the 10-plex TMT reagents, 
enabling relative quantification of 10 conditions in a single ex-
periment (66, 70). Labeled peptide extracts were combined to a sin-
gle sample per experiment, lyophilized, and subjected to LC-MS 
analysis.
Samples were injected into an UltiMate 3000 nanoRSLC (Dionex) 
coupled to a Q-Exactive mass spectrometer (Thermo Fisher Scientific). 
Peptides were separated on reversed-phase columns (Reprosil) at 
55°C by gradient elution (3.5 to 29% AcN in aqueous 0.1% FA, 
3.5% DMSO) in 120 min. The instruments were operated with 
Tune 2.4 and Xcalibur 3.0 build 63.
Mascot 2.4 (Matrix Science, Boston, MA) was used for protein 
identification by using a 10 parts per million mass tolerance for 
peptide precursors and 20 mD (HCD) mass tolerance for fragment 
ions. To create the FASTA file for mascot searching, all proteins corre-
sponding to the taxonomy “Plasmodium falciparum (isolate 3D7)” 
were downloaded from UniProt (release 20170621) and supplemented 
with common contaminant protein sequences of BSA, porcine 
trypsin, and mouse, rat, sheep, and dog keratins. To assess the 
FDR, “decoy” proteins (reverse of all protein sequences) were created 
and added to the database, resulting in a database containing a 
total of 14,266 protein sequences, 50% forward and 50% reverse.
Unless stated otherwise, we accepted protein identifications as 
follows: (i) For single-spectrum to sequence assignments, we required 
this assignment to be the best match and a minimum Mascot score 
of 31 and a 10× difference of this assignment over the next best as-
signment. On the basis of these criteria, the decoy search results 
indicated <1% FDR. (ii) For multiple spectrum to sequence assign-
ments and using the same parameters, the decoy search results indi-
cated <0.1% FDR. Quantified proteins were required to contain 
at least two unique peptide matches. FDR for quantified proteins 
was <0.1%.
P. falciparum phosphoproteomics
Parasite pellets were treated as previously described (71). Briefly, schi-
zont pellets were resuspended in 1 ml of 8 M urea in 50 mM Hepes 
(pH 8.5), containing protease and phosphatase inhibitors and ben-
zonase (100 U/ml; Sigma-Aldrich). Proteins were extracted from the 
pellets by sonication. Samples were incubated on ice for 10 min and 
centrifuged for 30 min at 14,000 rpm at 4°C. Protein content was 
estimated by a BCA protein assay, and 200 g of each sample was 
reduced with 10 mM DTT for 25 min at 56°C and then alkylated 
with 20 mM iodoacetamide for 30 min at room temperature. Sam-
ples were digested initially with LysC (Wako) at 37°C for 2.5 hours 
and subsequently with 10 g of trypsin (modified sequencing grade, 
Promega) overnight. After acidification, C18 MacroSpin columns 
(Nest Group) were used to clean up the digested peptide solutions 
and the eluted peptides dried by vacuum centrifugation. Samples 
were resuspended in 50 mM Hepes and labeled using the 0.8 mg 
Tandem Mass Tag 10plex isobaric reagent kit (Thermo Fisher 
Scientific) following the manufacturer’s instructions. The eluted 
TMT- labeled peptides were dried by vacuum centrifugation, and 
phosphopeptide enrichment was subsequently carried out using the 
sequential metal oxide affinity chromatography strategy with High 
Select TiO2 and Fe-NTA enrichment kits (Thermo Fisher Scientific). 
Eluates were combined before fractionation with the Pierce High pH 
Reversed-Phase Peptide Fractionation kit (Thermo Fisher Scientific). 
The dried TMT-labeled phosphopeptide fractions generated were 
resuspended in 0.1% TFA for LC-MS/MS analysis using a UltiMate 
3000 RSLCnano system (Thermo Fisher Scientific) interfaced with 
an Orbitrap Fusion Lumos (Thermo Fisher Scientific). Each peptide 
fraction was preconcentrated on an Acclaim PepMap 100 trapping 
column before separation on a 50-cm, 75-m I.D. EASY-Spray PepMap 
column over a 3-hour gradient run at 40°C, eluted directly into the 
mass spectrometer. The instrument was run in data-dependent 
acquisition mode with the most abundant peptides selected for MS/
MS fragmentation. Two replicate injections were made for each frac-
tion with different fragmentation methods based on the MS2 HCD 
and MSA SPS MS3 strategies described (72). The acquired raw mass 
spectrometric data were processed in MaxQuant (73) (v1.6.2.10) 
and searched against UniProt Homo sapiens complete proteome 
canonical sequences (September 2019) and PlasmoDB. Fixed mod-
ifications were set as Carbamidomethyl (C) and variable modifica-
tions set as Oxidation (M) and Phospho (STY). The estimated FDR 
was set to 1% at the peptide, protein, and site levels. A maximum of 
two missed cleavages were allowed. Reporter ion MS2 or Reporter 
ion MS3 was appropriately selected for each raw file. Other param-
eters were used as preset in the software. The MaxQuant output file 
PhosphoSTY Sites.txt, an FDR-controlled site-based table compiled 
by MaxQuant from the relevant information about the identified 
peptides, was imported into Perseus (v1.4.0.2) for data evaluation. 
Sequence logos were generated by IceLogo (https://iomics.ugent.be/
icelogoserver/). Paired t tests were performed using R (R Core Team, 
2017; www.R-project.org/). Significantly down-regulated genes from 
PfPKG and PfICM1 phosphoproteomes were used for enrichment 
of GO terms in PlasmoDB using a cutoff P value of 0.05. Results were 
visualized using REVIGO (74) with the P. falciparum database and 
similarity: 0.7, semantic similarity measure: SimRel. Plots were made 
using R (R Core Team, 2017; www.R-project.org/) package ggplot2 (75).
Balestra et al., Sci. Adv. 2021; 7 : eabe5396     24 March 2021




Samples (about 100 l of packed cell volume) were diluted with 
25 l of Laemmli 5× buffer and sonicated 6× 30 s at 70% amplitude 
and 0.5 pulse (30 s on ice between each cycle). Samples were heated 
5 min at 65°C and loaded onto a Novex Wedgewell 12% tris-glycine 
gel (Invitrogen). Each sample was loaded on two different wells, and 
protein’s migration was then performed according to the manufac-
turer’s instructions. Proteins were then stained with Coomassie blue. 
For each lane, a band between 180 and 220 kDa was cut and de-
stained by incubation in 100 l of 30% AcN in 50 mM AB for 15 min 
at room temperature. Proteins were reduced by incubation of gel 
pieces for 35  min at 56°C in 100 l of 10 mM DTE in 50 mM 
AB. DTE solution was then replaced by 100 l of 55 mM iodoacet-
amide in 50 mM AB, and proteins were alkylated by incubation of 
the gel pieces for 30 min at room temperature in the dark. Gel pieces 
were then washed for 10 min with 100 l of 50 mM AB and dehy-
drated for 10  min with 100 l of 30% AcN. Gel pieces were then 
dried for 30 min in a vacuum centrifuge. Dried pieces of gel were 
rehydrated for 45 min at 4°C with 70 l of trypsin (6.25 ng/l in AB 
50 mM) and then incubated overnight at 37°C. The supernatant 
was transferred to a new polypropylene tube, and two additional 
peptide extraction were performed with 70 l of 1% TFA and 100 l 
of 50% ACN, respectively; 0.1% TFA. Extractions were pooled and 
dried under speed vacuum.
Titanium dioxide enrichment
Phosphopeptide enrichment was performed as previously described 
(76). Briefly, stage tips were prepared using Glass Microfiber Filters 
(Whatman) and 5-m TiO2 beads (GL Sciences). Beads were sus-
pended with 0.1% TFA in 80% AcN and inserted onto a gel-loading 
tip to create a 5-mm-long column. Peptides samples were dissolved 
in 1 M glycolic acid 2% TFA in 80% AcN and loaded onto dedicated 
TiO2 columns by centrifugation 1 min at 6000 rpm. Columns were 
then washed four times with 1 M glycolic acid 2% TFA in 80% AcN 
and four times with 0.1% TFA in 80% AcN. Bounded peptides were 
eluted first with 3% NH4OH and then with 0.1% TFA in 80% AcN. Eluates 
were then acidified with 5% TFA and dried under speed vacuum.
Fe-NTA enrichment
Flow through from TiO2 beads were enriched using homemade 
stage tips as described before but containing beads from the High- 
Select Fe-NTA Phosphopeptide Enrichment Kit (Thermo Fisher 
Scientific). Enrichment was performed according to the manufac-
turer’s instructions.
Liquid chromatography electrospray ionization tandem  
mass spectrometry
Samples were diluted in 10 l of loading buffer (5% CH3CN and 
0.1% FA), and 6 l was injected on column. LC-ESI-MS/MS was per-
formed on an Orbitrap Fusion Lumos Tribrid mass spectrometer 
(Thermo Fisher Scientific) equipped with an Easy nLC1200 liquid 
chromatography system (Thermo Fisher Scientific). Peptides were 
trapped on an Acclaim PepMap 100, 3-m C18, 75 m by 20 mm 
nano-trap column (Thermo Fisher Scientific) and separated on a 75 m 
by 500 mm, C18 ReproSil-Pur from Dr. Maisch GmBH, 1.9 m and 
100 Å, homemade column. The analytical separation was run for 
90  min using a gradient of H2O/FA 99.9%/0.1% (solvent A) and 
CH3CN/FA 80%/0.1% (solvent B). The gradient was run as follows: 
95% A and 5% B for 0 to 5 min, then to 65% A and 35% B for 60 min, 
and lastly to 5% A and 95% B for 10 min with a stay for 15 min at 
this composition. Flow rate was of 250 nl/min. DDA was performed 
with MS1 full scan at a resolution of 120,000 FWHM followed by as 
many subsequent MS2 scans on selected precursors as possible with-
in 3-s maximum cycle time. MS1 was performed in the Orbitrap 
with an AGC target of 4 × 105, a maximum injection time of 50 ms, 
and a scan range from 375 to 1500 m/z. MS2 was performed in the 
Orbitrap at a resolution of 30,000 FWHM with an AGC target at 
5 × 104 and a maximum injection time of 54 ms. Isolation windows 
was set at 1.6 m/z, and 30% normalized collision energy was used 
for HCD.
Database search
Raw data were processed using Proteome Discoverer 2.3 software 
(Thermo Fisher Scientific). Briefly, spectra were extracted and searched 
against the P. berghei ANKA database (PlasmoDB.org, release 38, 
5076 entries) combined with an in-house database of common con-
taminants using Mascot (Matrix Science, London, UK; version 2.5.1). 
Trypsin was selected as the enzyme, with one potential missed cleavage. 
Precursor ion tolerance was set to 10 ppm and fragment ion toler-
ance to 0.02 Da. Carbamidomethylation of cysteine was specified as 
fixed modification. Deamidation of asparagine and glutamine, oxi-
dation of methionine, as well as phosphorylation of serine, threonine, 
and tyrosine were specified as variable modifications. Peptide-spectrum 
matches were validated using the target decoy PSM validator node 
with a target FDR of 0.01 and a Delta Cn of 0.5. For label-free quan-
tification, features and chromatographic peaks were detected using 
the “Minora Feature Detector” node with the default parameters. 
PSM and peptides were filtered with a FDR of 1% and then grouped 
to proteins with again an FDR of 1% and using only peptides with a 
high confidence level. Both unique and razor peptides were used for 
quantitation, and protein abundances are calculated as the average 
of the three most abundant distinct peptide groups. The abundances 
were normalized on the “total peptide amount,” then “protein abundance–
based” option was selected for protein ratio calculation, and associ-
ated P values were calculated with an analysis of variance (ANOVA) 
test (individual proteins).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/13/eabe5396/DC1
View/request a protocol for this paper from Bio-protocol.
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